Cargando…
Preexisting Oral Anticoagulant Therapy Ameliorates Prognosis in Hospitalized COVID-19 Patients
Objective: Altered coagulation parameters in COVID-19 patients is associated with a poor prognosis. We tested whether COVID-19 patients on chronic oral anticoagulants (cOACs) for thromboembolism prophylaxis could receive protection from developing more severe phenotypes of the disease. Approach and...
Autores principales: | Iaccarino, Guido, Grassi, Guido, Borghi, Claudio, Grassi, Davide, Mancusi, Costantino, Muiesan, Maria Lorenza, Salvetti, Massimo, Volpe, Massimo, Ferri, Claudio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155285/ https://www.ncbi.nlm.nih.gov/pubmed/34055928 http://dx.doi.org/10.3389/fcvm.2021.633878 |
Ejemplares similares
-
Clinical Characteristics and Outcomes of Patients with COVID-19 Infection: The Results of the SARS-RAS Study of the Italian Society of Hypertension
por: Mancusi, Costantino, et al.
Publicado: (2021) -
Gender differences in predictors of intensive care units admission among COVID-19 patients: The results of the SARS-RAS study of the Italian Society of Hypertension
por: Iaccarino, Guido, et al.
Publicado: (2020) -
Correction: Gender differences in predictors of intensive care units admission among COVID-19 patients: The results of the SARS-RAS study of the Italian Society of Hypertension
por: Iaccarino, Guido, et al.
Publicado: (2021) -
Correction: Gender differences in predictors of intensive care units admission among COVID-19 patients: The results of the SARS-RAS study of the Italian Society of Hypertension
por: Iaccarino, Guido, et al.
Publicado: (2022) -
Renin-Angiotensin System Inhibition in Cardiovascular Patients at the Time of COVID19: Much Ado for Nothing? A Statement of Activity from the Directors of the Board and the Scientific Directors of the Italian Society of Hypertension
por: Iaccarino, Guido, et al.
Publicado: (2020)